Global Influenzavirus B Infection Drug Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Influenzavirus B Infection Drug Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Influenzavirus B Infection Drug by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Influenzavirus B Infection Drug by Country/Region, 2017, 2022 & 2028

2.2 Influenzavirus B Infection Drug Segment by Type

2.2.1 APP-309

2.2.2 CF-403

2.2.3 GC-3106A

2.2.4 KIN-1400

2.2.5 Others

2.3 Influenzavirus B Infection Drug Sales by Type

2.3.1 Global Influenzavirus B Infection Drug Sales Market Share by Type (2017-2022)

2.3.2 Global Influenzavirus B Infection Drug Revenue and Market Share by Type (2017-2022)

2.3.3 Global Influenzavirus B Infection Drug Sale Price by Type (2017-2022)

2.4 Influenzavirus B Infection Drug Segment by Application

2.4.1 Clinic

2.4.2 Hospital

2.4.3 Others

2.5 Influenzavirus B Infection Drug Sales by Application

2.5.1 Global Influenzavirus B Infection Drug Sale Market Share by Application (2017-2022)

2.5.2 Global Influenzavirus B Infection Drug Revenue and Market Share by Application (2017-2022)

2.5.3 Global Influenzavirus B Infection Drug Sale Price by Application (2017-2022)

3 Global Influenzavirus B Infection Drug by Company

3.1 Global Influenzavirus B Infection Drug Breakdown Data by Company

3.1.1 Global Influenzavirus B Infection Drug Annual Sales by Company (2020-2022)

3.1.2 Global Influenzavirus B Infection Drug Sales Market Share by Company (2020-2022)

3.2 Global Influenzavirus B Infection Drug Annual Revenue by Company (2020-2022)

3.2.1 Global Influenzavirus B Infection Drug Revenue by Company (2020-2022)

3.2.2 Global Influenzavirus B Infection Drug Revenue Market Share by Company (2020-2022)

3.3 Global Influenzavirus B Infection Drug Sale Price by Company

3.4 Key Manufacturers Influenzavirus B Infection Drug Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Influenzavirus B Infection Drug Product Location Distribution

3.4.2 Players Influenzavirus B Infection Drug Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Influenzavirus B Infection Drug by Geographic Region

4.1 World Historic Influenzavirus B Infection Drug Market Size by Geographic Region (2017-2022)

4.1.1 Global Influenzavirus B Infection Drug Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Influenzavirus B Infection Drug Annual Revenue by Geographic Region

4.2 World Historic Influenzavirus B Infection Drug Market Size by Country/Region (2017-2022)

4.2.1 Global Influenzavirus B Infection Drug Annual Sales by Country/Region (2017-2022)

4.2.2 Global Influenzavirus B Infection Drug Annual Revenue by Country/Region

4.3 Americas Influenzavirus B Infection Drug Sales Growth

4.4 APAC Influenzavirus B Infection Drug Sales Growth

4.5 Europe Influenzavirus B Infection Drug Sales Growth

4.6 Middle East & Africa Influenzavirus B Infection Drug Sales Growth

5 Americas

5.1 Americas Influenzavirus B Infection Drug Sales by Country

5.1.1 Americas Influenzavirus B Infection Drug Sales by Country (2017-2022)

5.1.2 Americas Influenzavirus B Infection Drug Revenue by Country (2017-2022)

5.2 Americas Influenzavirus B Infection Drug Sales by Type

5.3 Americas Influenzavirus B Infection Drug Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Influenzavirus B Infection Drug Sales by Region

6.1.1 APAC Influenzavirus B Infection Drug Sales by Region (2017-2022)

6.1.2 APAC Influenzavirus B Infection Drug Revenue by Region (2017-2022)

6.2 APAC Influenzavirus B Infection Drug Sales by Type

6.3 APAC Influenzavirus B Infection Drug Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Influenzavirus B Infection Drug by Country

7.1.1 Europe Influenzavirus B Infection Drug Sales by Country (2017-2022)

7.1.2 Europe Influenzavirus B Infection Drug Revenue by Country (2017-2022)

7.2 Europe Influenzavirus B Infection Drug Sales by Type

7.3 Europe Influenzavirus B Infection Drug Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Influenzavirus B Infection Drug by Country

8.1.1 Middle East & Africa Influenzavirus B Infection Drug Sales by Country (2017-2022)

8.1.2 Middle East & Africa Influenzavirus B Infection Drug Revenue by Country (2017-2022)

8.2 Middle East & Africa Influenzavirus B Infection Drug Sales by Type

8.3 Middle East & Africa Influenzavirus B Infection Drug Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Influenzavirus B Infection Drug

10.3 Manufacturing Process Analysis of Influenzavirus B Infection Drug

10.4 Industry Chain Structure of Influenzavirus B Infection Drug

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Influenzavirus B Infection Drug Distributors

11.3 Influenzavirus B Infection Drug Customer

12 World Forecast Review for Influenzavirus B Infection Drug by Geographic Region

12.1 Global Influenzavirus B Infection Drug Market Size Forecast by Region

12.1.1 Global Influenzavirus B Infection Drug Forecast by Region (2023-2028)

12.1.2 Global Influenzavirus B Infection Drug Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Influenzavirus B Infection Drug Forecast by Type

12.7 Global Influenzavirus B Infection Drug Forecast by Application

13 Key Players Analysis

13.1 AbbVie Inc

13.1.1 AbbVie Inc Company Information

13.1.2 AbbVie Inc Influenzavirus B Infection Drug Product Offered

13.1.3 AbbVie Inc Influenzavirus B Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 AbbVie Inc Main Business Overview

13.1.5 AbbVie Inc Latest Developments

13.2 Adimmune Corp

13.2.1 Adimmune Corp Company Information

13.2.2 Adimmune Corp Influenzavirus B Infection Drug Product Offered

13.2.3 Adimmune Corp Influenzavirus B Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Adimmune Corp Main Business Overview

13.2.5 Adimmune Corp Latest Developments

13.3 Altravax Inc

13.3.1 Altravax Inc Company Information

13.3.2 Altravax Inc Influenzavirus B Infection Drug Product Offered

13.3.3 Altravax Inc Influenzavirus B Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Altravax Inc Main Business Overview

13.3.5 Altravax Inc Latest Developments

13.4 Amarillo Biosciences Inc

13.4.1 Amarillo Biosciences Inc Company Information

13.4.2 Amarillo Biosciences Inc Influenzavirus B Infection Drug Product Offered

13.4.3 Amarillo Biosciences Inc Influenzavirus B Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Amarillo Biosciences Inc Main Business Overview

13.4.5 Amarillo Biosciences Inc Latest Developments

13.5 Aphios Corp

13.5.1 Aphios Corp Company Information

13.5.2 Aphios Corp Influenzavirus B Infection Drug Product Offered

13.5.3 Aphios Corp Influenzavirus B Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Aphios Corp Main Business Overview

13.5.5 Aphios Corp Latest Developments

13.6 BioCryst Pharmaceuticals Inc

13.6.1 BioCryst Pharmaceuticals Inc Company Information

13.6.2 BioCryst Pharmaceuticals Inc Influenzavirus B Infection Drug Product Offered

13.6.3 BioCryst Pharmaceuticals Inc Influenzavirus B Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 BioCryst Pharmaceuticals Inc Main Business Overview

13.6.5 BioCryst Pharmaceuticals Inc Latest Developments

13.7 Cadila Healthcare Ltd

13.7.1 Cadila Healthcare Ltd Company Information

13.7.2 Cadila Healthcare Ltd Influenzavirus B Infection Drug Product Offered

13.7.3 Cadila Healthcare Ltd Influenzavirus B Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Cadila Healthcare Ltd Main Business Overview

13.7.5 Cadila Healthcare Ltd Latest Developments

13.8 ContraFect Corp

13.8.1 ContraFect Corp Company Information

13.8.2 ContraFect Corp Influenzavirus B Infection Drug Product Offered

13.8.3 ContraFect Corp Influenzavirus B Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 ContraFect Corp Main Business Overview

13.8.5 ContraFect Corp Latest Developments

13.9 Daiichi Sankyo Company Ltd

13.9.1 Daiichi Sankyo Company Ltd Company Information

13.9.2 Daiichi Sankyo Company Ltd Influenzavirus B Infection Drug Product Offered

13.9.3 Daiichi Sankyo Company Ltd Influenzavirus B Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Daiichi Sankyo Company Ltd Main Business Overview

13.9.5 Daiichi Sankyo Company Ltd Latest Developments

13.10 Fujifilm Holdings Corporation

13.10.1 Fujifilm Holdings Corporation Company Information

13.10.2 Fujifilm Holdings Corporation Influenzavirus B Infection Drug Product Offered

13.10.3 Fujifilm Holdings Corporation Influenzavirus B Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Fujifilm Holdings Corporation Main Business Overview

13.10.5 Fujifilm Holdings Corporation Latest Developments

13.11 GlaxoSmithKline Plc

13.11.1 GlaxoSmithKline Plc Company Information

13.11.2 GlaxoSmithKline Plc Influenzavirus B Infection Drug Product Offered

13.11.3 GlaxoSmithKline Plc Influenzavirus B Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 GlaxoSmithKline Plc Main Business Overview

13.11.5 GlaxoSmithKline Plc Latest Developments

13.12 Green Cross Corp

13.12.1 Green Cross Corp Company Information

13.12.2 Green Cross Corp Influenzavirus B Infection Drug Product Offered

13.12.3 Green Cross Corp Influenzavirus B Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Green Cross Corp Main Business Overview

13.12.5 Green Cross Corp Latest Developments

13.13 Inovio Pharmaceuticals Inc

13.13.1 Inovio Pharmaceuticals Inc Company Information

13.13.2 Inovio Pharmaceuticals Inc Influenzavirus B Infection Drug Product Offered

13.13.3 Inovio Pharmaceuticals Inc Influenzavirus B Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Inovio Pharmaceuticals Inc Main Business Overview

13.13.5 Inovio Pharmaceuticals Inc Latest Developments

13.14 Kineta Inc

13.14.1 Kineta Inc Company Information

13.14.2 Kineta Inc Influenzavirus B Infection Drug Product Offered

13.14.3 Kineta Inc Influenzavirus B Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Kineta Inc Main Business Overview

13.14.5 Kineta Inc Latest Developments

13.15 Medicago Inc

13.15.1 Medicago Inc Company Information

13.15.2 Medicago Inc Influenzavirus B Infection Drug Product Offered

13.15.3 Medicago Inc Influenzavirus B Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Medicago Inc Main Business Overview

13.15.5 Medicago Inc Latest Developments

13.16 MedImmune LLC

13.16.1 MedImmune LLC Company Information

13.16.2 MedImmune LLC Influenzavirus B Infection Drug Product Offered

13.16.3 MedImmune LLC Influenzavirus B Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 MedImmune LLC Main Business Overview

13.16.5 MedImmune LLC Latest Developments

13.17 Mucosis BV

13.17.1 Mucosis BV Company Information

13.17.2 Mucosis BV Influenzavirus B Infection Drug Product Offered

13.17.3 Mucosis BV Influenzavirus B Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Mucosis BV Main Business Overview

13.17.5 Mucosis BV Latest Developments

13.18 Novavax Inc

13.18.1 Novavax Inc Company Information

13.18.2 Novavax Inc Influenzavirus B Infection Drug Product Offered

13.18.3 Novavax Inc Influenzavirus B Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 Novavax Inc Main Business Overview

13.18.5 Novavax Inc Latest Developments

13.19 Park Active Molecules

13.19.1 Park Active Molecules Company Information

13.19.2 Park Active Molecules Influenzavirus B Infection Drug Product Offered

13.19.3 Park Active Molecules Influenzavirus B Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.19.4 Park Active Molecules Main Business Overview

13.19.5 Park Active Molecules Latest Developments

13.20 Romark Laboratories LC

13.20.1 Romark Laboratories LC Company Information

13.20.2 Romark Laboratories LC Influenzavirus B Infection Drug Product Offered

13.20.3 Romark Laboratories LC Influenzavirus B Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.20.4 Romark Laboratories LC Main Business Overview

13.20.5 Romark Laboratories LC Latest Developments

13.21 Sanofi

13.21.1 Sanofi Company Information

13.21.2 Sanofi Influenzavirus B Infection Drug Product Offered

13.21.3 Sanofi Influenzavirus B Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.21.4 Sanofi Main Business Overview

13.21.5 Sanofi Latest Developments

13.22 Sanofi Pasteur SA

13.22.1 Sanofi Pasteur SA Company Information

13.22.2 Sanofi Pasteur SA Influenzavirus B Infection Drug Product Offered

13.22.3 Sanofi Pasteur SA Influenzavirus B Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.22.4 Sanofi Pasteur SA Main Business Overview

13.22.5 Sanofi Pasteur SA Latest Developments

13.23 Shionogi & Co Ltd

13.23.1 Shionogi & Co Ltd Company Information

13.23.2 Shionogi & Co Ltd Influenzavirus B Infection Drug Product Offered

13.23.3 Shionogi & Co Ltd Influenzavirus B Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.23.4 Shionogi & Co Ltd Main Business Overview

13.23.5 Shionogi & Co Ltd Latest Developments

13.24 SK Chemicals Co Ltd

13.24.1 SK Chemicals Co Ltd Company Information

13.24.2 SK Chemicals Co Ltd Influenzavirus B Infection Drug Product Offered

13.24.3 SK Chemicals Co Ltd Influenzavirus B Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.24.4 SK Chemicals Co Ltd Main Business Overview

13.24.5 SK Chemicals Co Ltd Latest Developments

13.25 TSRL Inc

13.25.1 TSRL Inc Company Information

13.25.2 TSRL Inc Influenzavirus B Infection Drug Product Offered

13.25.3 TSRL Inc Influenzavirus B Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.25.4 TSRL Inc Main Business Overview

13.25.5 TSRL Inc Latest Developments

13.26 Vaxart Inc

13.26.1 Vaxart Inc Company Information

13.26.2 Vaxart Inc Influenzavirus B Infection Drug Product Offered

13.26.3 Vaxart Inc Influenzavirus B Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.26.4 Vaxart Inc Main Business Overview

13.26.5 Vaxart Inc Latest Developments

13.27 Vectura Group Plc

13.27.1 Vectura Group Plc Company Information

13.27.2 Vectura Group Plc Influenzavirus B Infection Drug Product Offered

13.27.3 Vectura Group Plc Influenzavirus B Infection Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.27.4 Vectura Group Plc Main Business Overview

13.27.5 Vectura Group Plc Latest Developments

14 Research Findings and Conclusion

Table 1. Influenzavirus B Infection Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Influenzavirus B Infection Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of APP-309

Table 4. Major Players of CF-403

Table 5. Major Players of GC-3106A

Table 6. Major Players of KIN-1400

Table 7. Major Players of Others

Table 8. Global Influenzavirus B Infection Drug Sales by Type (2017-2022) & (K Pcs)

Table 9. Global Influenzavirus B Infection Drug Sales Market Share by Type (2017-2022)

Table 10. Global Influenzavirus B Infection Drug Revenue by Type (2017-2022) & ($ million)

Table 11. Global Influenzavirus B Infection Drug Revenue Market Share by Type (2017-2022)

Table 12. Global Influenzavirus B Infection Drug Sale Price by Type (2017-2022) & (USD/Pcs)

Table 13. Global Influenzavirus B Infection Drug Sales by Application (2017-2022) & (K Pcs)

Table 14. Global Influenzavirus B Infection Drug Sales Market Share by Application (2017-2022)

Table 15. Global Influenzavirus B Infection Drug Revenue by Application (2017-2022)

Table 16. Global Influenzavirus B Infection Drug Revenue Market Share by Application (2017-2022)

Table 17. Global Influenzavirus B Infection Drug Sale Price by Application (2017-2022) & (USD/Pcs)

Table 18. Global Influenzavirus B Infection Drug Sales by Company (2020-2022) & (K Pcs)

Table 19. Global Influenzavirus B Infection Drug Sales Market Share by Company (2020-2022)

Table 20. Global Influenzavirus B Infection Drug Revenue by Company (2020-2022) ($ Millions)

Table 21. Global Influenzavirus B Infection Drug Revenue Market Share by Company (2020-2022)

Table 22. Global Influenzavirus B Infection Drug Sale Price by Company (2020-2022) & (USD/Pcs)

Table 23. Key Manufacturers Influenzavirus B Infection Drug Producing Area Distribution and Sales Area

Table 24. Players Influenzavirus B Infection Drug Products Offered

Table 25. Influenzavirus B Infection Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 26. New Products and Potential Entrants

Table 27. Mergers & Acquisitions, Expansion

Table 28. Global Influenzavirus B Infection Drug Sales by Geographic Region (2017-2022) & (K Pcs)

Table 29. Global Influenzavirus B Infection Drug Sales Market Share Geographic Region (2017-2022)

Table 30. Global Influenzavirus B Infection Drug Revenue by Geographic Region (2017-2022) & ($ millions)

Table 31. Global Influenzavirus B Infection Drug Revenue Market Share by Geographic Region (2017-2022)

Table 32. Global Influenzavirus B Infection Drug Sales by Country/Region (2017-2022) & (K Pcs)

Table 33. Global Influenzavirus B Infection Drug Sales Market Share by Country/Region (2017-2022)

Table 34. Global Influenzavirus B Infection Drug Revenue by Country/Region (2017-2022) & ($ millions)

Table 35. Global Influenzavirus B Infection Drug Revenue Market Share by Country/Region (2017-2022)

Table 36. Americas Influenzavirus B Infection Drug Sales by Country (2017-2022) & (K Pcs)

Table 37. Americas Influenzavirus B Infection Drug Sales Market Share by Country (2017-2022)

Table 38. Americas Influenzavirus B Infection Drug Revenue by Country (2017-2022) & ($ Millions)

Table 39. Americas Influenzavirus B Infection Drug Revenue Market Share by Country (2017-2022)

Table 40. Americas Influenzavirus B Infection Drug Sales by Type (2017-2022) & (K Pcs)

Table 41. Americas Influenzavirus B Infection Drug Sales Market Share by Type (2017-2022)

Table 42. Americas Influenzavirus B Infection Drug Sales by Application (2017-2022) & (K Pcs)

Table 43. Americas Influenzavirus B Infection Drug Sales Market Share by Application (2017-2022)

Table 44. APAC Influenzavirus B Infection Drug Sales by Region (2017-2022) & (K Pcs)

Table 45. APAC Influenzavirus B Infection Drug Sales Market Share by Region (2017-2022)

Table 46. APAC Influenzavirus B Infection Drug Revenue by Region (2017-2022) & ($ Millions)

Table 47. APAC Influenzavirus B Infection Drug Revenue Market Share by Region (2017-2022)

Table 48. APAC Influenzavirus B Infection Drug Sales by Type (2017-2022) & (K Pcs)

Table 49. APAC Influenzavirus B Infection Drug Sales Market Share by Type (2017-2022)

Table 50. APAC Influenzavirus B Infection Drug Sales by Application (2017-2022) & (K Pcs)

Table 51. APAC Influenzavirus B Infection Drug Sales Market Share by Application (2017-2022)

Table 52. Europe Influenzavirus B Infection Drug Sales by Country (2017-2022) & (K Pcs)

Table 53. Europe Influenzavirus B Infection Drug Sales Market Share by Country (2017-2022)

Table 54. Europe Influenzavirus B Infection Drug Revenue by Country (2017-2022) & ($ Millions)

Table 55. Europe Influenzavirus B Infection Drug Revenue Market Share by Country (2017-2022)

Table 56. Europe Influenzavirus B Infection Drug Sales by Type (2017-2022) & (K Pcs)

Table 57. Europe Influenzavirus B Infection Drug Sales Market Share by Type (2017-2022)

Table 58. Europe Influenzavirus B Infection Drug Sales by Application (2017-2022) & (K Pcs)

Table 59. Europe Influenzavirus B Infection Drug Sales Market Share by Application (2017-2022)

Table 60. Middle East & Africa Influenzavirus B Infection Drug Sales by Country (2017-2022) & (K Pcs)

Table 61. Middle East & Africa Influenzavirus B Infection Drug Sales Market Share by Country (2017-2022)

Table 62. Middle East & Africa Influenzavirus B Infection Drug Revenue by Country (2017-2022) & ($ Millions)

Table 63. Middle East & Africa Influenzavirus B Infection Drug Revenue Market Share by Country (2017-2022)

Table 64. Middle East & Africa Influenzavirus B Infection Drug Sales by Type (2017-2022) & (K Pcs)

Table 65. Middle East & Africa Influenzavirus B Infection Drug Sales Market Share by Type (2017-2022)

Table 66. Middle East & Africa Influenzavirus B Infection Drug Sales by Application (2017-2022) & (K Pcs)

Table 67. Middle East & Africa Influenzavirus B Infection Drug Sales Market Share by Application (2017-2022)

Table 68. Key Market Drivers & Growth Opportunities of Influenzavirus B Infection Drug

Table 69. Key Market Challenges & Risks of Influenzavirus B Infection Drug

Table 70. Key Industry Trends of Influenzavirus B Infection Drug

Table 71. Influenzavirus B Infection Drug Raw Material

Table 72. Key Suppliers of Raw Materials

Table 73. Influenzavirus B Infection Drug Distributors List

Table 74. Influenzavirus B Infection Drug Customer List

Table 75. Global Influenzavirus B Infection Drug Sales Forecast by Region (2023-2028) & (K Pcs)

Table 76. Global Influenzavirus B Infection Drug Sales Market Forecast by Region

Table 77. Global Influenzavirus B Infection Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 78. Global Influenzavirus B Infection Drug Revenue Market Share Forecast by Region (2023-2028)

Table 79. Americas Influenzavirus B Infection Drug Sales Forecast by Country (2023-2028) & (K Pcs)

Table 80. Americas Influenzavirus B Infection Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 81. APAC Influenzavirus B Infection Drug Sales Forecast by Region (2023-2028) & (K Pcs)

Table 82. APAC Influenzavirus B Infection Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 83. Europe Influenzavirus B Infection Drug Sales Forecast by Country (2023-2028) & (K Pcs)

Table 84. Europe Influenzavirus B Infection Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Middle East & Africa Influenzavirus B Infection Drug Sales Forecast by Country (2023-2028) & (K Pcs)

Table 86. Middle East & Africa Influenzavirus B Infection Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 87. Global Influenzavirus B Infection Drug Sales Forecast by Type (2023-2028) & (K Pcs)

Table 88. Global Influenzavirus B Infection Drug Sales Market Share Forecast by Type (2023-2028)

Table 89. Global Influenzavirus B Infection Drug Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 90. Global Influenzavirus B Infection Drug Revenue Market Share Forecast by Type (2023-2028)

Table 91. Global Influenzavirus B Infection Drug Sales Forecast by Application (2023-2028) & (K Pcs)

Table 92. Global Influenzavirus B Infection Drug Sales Market Share Forecast by Application (2023-2028)

Table 93. Global Influenzavirus B Infection Drug Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 94. Global Influenzavirus B Infection Drug Revenue Market Share Forecast by Application (2023-2028)

Table 95. AbbVie Inc Basic Information, Influenzavirus B Infection Drug Manufacturing Base, Sales Area and Its Competitors

Table 96. AbbVie Inc Influenzavirus B Infection Drug Product Offered

Table 97. AbbVie Inc Influenzavirus B Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 98. AbbVie Inc Main Business

Table 99. AbbVie Inc Latest Developments

Table 100. Adimmune Corp Basic Information, Influenzavirus B Infection Drug Manufacturing Base, Sales Area and Its Competitors

Table 101. Adimmune Corp Influenzavirus B Infection Drug Product Offered

Table 102. Adimmune Corp Influenzavirus B Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 103. Adimmune Corp Main Business

Table 104. Adimmune Corp Latest Developments

Table 105. Altravax Inc Basic Information, Influenzavirus B Infection Drug Manufacturing Base, Sales Area and Its Competitors

Table 106. Altravax Inc Influenzavirus B Infection Drug Product Offered

Table 107. Altravax Inc Influenzavirus B Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 108. Altravax Inc Main Business

Table 109. Altravax Inc Latest Developments

Table 110. Amarillo Biosciences Inc Basic Information, Influenzavirus B Infection Drug Manufacturing Base, Sales Area and Its Competitors

Table 111. Amarillo Biosciences Inc Influenzavirus B Infection Drug Product Offered

Table 112. Amarillo Biosciences Inc Influenzavirus B Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 113. Amarillo Biosciences Inc Main Business

Table 114. Amarillo Biosciences Inc Latest Developments

Table 115. Aphios Corp Basic Information, Influenzavirus B Infection Drug Manufacturing Base, Sales Area and Its Competitors

Table 116. Aphios Corp Influenzavirus B Infection Drug Product Offered

Table 117. Aphios Corp Influenzavirus B Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 118. Aphios Corp Main Business

Table 119. Aphios Corp Latest Developments

Table 120. BioCryst Pharmaceuticals Inc Basic Information, Influenzavirus B Infection Drug Manufacturing Base, Sales Area and Its Competitors

Table 121. BioCryst Pharmaceuticals Inc Influenzavirus B Infection Drug Product Offered

Table 122. BioCryst Pharmaceuticals Inc Influenzavirus B Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 123. BioCryst Pharmaceuticals Inc Main Business

Table 124. BioCryst Pharmaceuticals Inc Latest Developments

Table 125. Cadila Healthcare Ltd Basic Information, Influenzavirus B Infection Drug Manufacturing Base, Sales Area and Its Competitors

Table 126. Cadila Healthcare Ltd Influenzavirus B Infection Drug Product Offered

Table 127. Cadila Healthcare Ltd Influenzavirus B Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 128. Cadila Healthcare Ltd Main Business

Table 129. Cadila Healthcare Ltd Latest Developments

Table 130. ContraFect Corp Basic Information, Influenzavirus B Infection Drug Manufacturing Base, Sales Area and Its Competitors

Table 131. ContraFect Corp Influenzavirus B Infection Drug Product Offered

Table 132. ContraFect Corp Influenzavirus B Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 133. ContraFect Corp Main Business

Table 134. ContraFect Corp Latest Developments

Table 135. Daiichi Sankyo Company Ltd Basic Information, Influenzavirus B Infection Drug Manufacturing Base, Sales Area and Its Competitors

Table 136. Daiichi Sankyo Company Ltd Influenzavirus B Infection Drug Product Offered

Table 137. Daiichi Sankyo Company Ltd Influenzavirus B Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 138. Daiichi Sankyo Company Ltd Main Business

Table 139. Daiichi Sankyo Company Ltd Latest Developments

Table 140. Fujifilm Holdings Corporation Basic Information, Influenzavirus B Infection Drug Manufacturing Base, Sales Area and Its Competitors

Table 141. Fujifilm Holdings Corporation Influenzavirus B Infection Drug Product Offered

Table 142. Fujifilm Holdings Corporation Influenzavirus B Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 143. Fujifilm Holdings Corporation Main Business

Table 144. Fujifilm Holdings Corporation Latest Developments

Table 145. GlaxoSmithKline Plc Basic Information, Influenzavirus B Infection Drug Manufacturing Base, Sales Area and Its Competitors

Table 146. GlaxoSmithKline Plc Influenzavirus B Infection Drug Product Offered

Table 147. GlaxoSmithKline Plc Influenzavirus B Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 148. GlaxoSmithKline Plc Main Business

Table 149. GlaxoSmithKline Plc Latest Developments

Table 150. Green Cross Corp Basic Information, Influenzavirus B Infection Drug Manufacturing Base, Sales Area and Its Competitors

Table 151. Green Cross Corp Influenzavirus B Infection Drug Product Offered

Table 152. Green Cross Corp Influenzavirus B Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 153. Green Cross Corp Main Business

Table 154. Green Cross Corp Latest Developments

Table 155. Inovio Pharmaceuticals Inc Basic Information, Influenzavirus B Infection Drug Manufacturing Base, Sales Area and Its Competitors

Table 156. Inovio Pharmaceuticals Inc Influenzavirus B Infection Drug Product Offered

Table 157. Inovio Pharmaceuticals Inc Influenzavirus B Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 158. Inovio Pharmaceuticals Inc Main Business

Table 159. Inovio Pharmaceuticals Inc Latest Developments

Table 160. Kineta Inc Basic Information, Influenzavirus B Infection Drug Manufacturing Base, Sales Area and Its Competitors

Table 161. Kineta Inc Influenzavirus B Infection Drug Product Offered

Table 162. Kineta Inc Influenzavirus B Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 163. Kineta Inc Main Business

Table 164. Kineta Inc Latest Developments

Table 165. Medicago Inc Basic Information, Influenzavirus B Infection Drug Manufacturing Base, Sales Area and Its Competitors

Table 166. Medicago Inc Influenzavirus B Infection Drug Product Offered

Table 167. Medicago Inc Influenzavirus B Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 168. Medicago Inc Main Business

Table 169. Medicago Inc Latest Developments

Table 170. MedImmune LLC Basic Information, Influenzavirus B Infection Drug Manufacturing Base, Sales Area and Its Competitors

Table 171. MedImmune LLC Influenzavirus B Infection Drug Product Offered

Table 172. MedImmune LLC Influenzavirus B Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 173. MedImmune LLC Main Business

Table 174. MedImmune LLC Latest Developments

Table 175. Mucosis BV Basic Information, Influenzavirus B Infection Drug Manufacturing Base, Sales Area and Its Competitors

Table 176. Mucosis BV Influenzavirus B Infection Drug Product Offered

Table 177. Mucosis BV Influenzavirus B Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 178. Mucosis BV Main Business

Table 179. Mucosis BV Latest Developments

Table 180. Novavax Inc Basic Information, Influenzavirus B Infection Drug Manufacturing Base, Sales Area and Its Competitors

Table 181. Novavax Inc Influenzavirus B Infection Drug Product Offered

Table 182. Novavax Inc Influenzavirus B Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 183. Novavax Inc Main Business

Table 184. Novavax Inc Latest Developments

Table 185. Park Active Molecules Basic Information, Influenzavirus B Infection Drug Manufacturing Base, Sales Area and Its Competitors

Table 186. Park Active Molecules Influenzavirus B Infection Drug Product Offered

Table 187. Park Active Molecules Influenzavirus B Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 188. Park Active Molecules Main Business

Table 189. Park Active Molecules Latest Developments

Table 190. Romark Laboratories LC Basic Information, Influenzavirus B Infection Drug Manufacturing Base, Sales Area and Its Competitors

Table 191. Romark Laboratories LC Influenzavirus B Infection Drug Product Offered

Table 192. Romark Laboratories LC Influenzavirus B Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 193. Romark Laboratories LC Main Business

Table 194. Romark Laboratories LC Latest Developments

Table 195. Sanofi Basic Information, Influenzavirus B Infection Drug Manufacturing Base, Sales Area and Its Competitors

Table 196. Sanofi Influenzavirus B Infection Drug Product Offered

Table 197. Sanofi Influenzavirus B Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 198. Sanofi Main Business

Table 199. Sanofi Latest Developments

Table 200. Sanofi Pasteur SA Basic Information, Influenzavirus B Infection Drug Manufacturing Base, Sales Area and Its Competitors

Table 201. Sanofi Pasteur SA Influenzavirus B Infection Drug Product Offered

Table 202. Sanofi Pasteur SA Influenzavirus B Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 203. Sanofi Pasteur SA Main Business

Table 204. Sanofi Pasteur SA Latest Developments

Table 205. Shionogi & Co Ltd Basic Information, Influenzavirus B Infection Drug Manufacturing Base, Sales Area and Its Competitors

Table 206. Shionogi & Co Ltd Influenzavirus B Infection Drug Product Offered

Table 207. Shionogi & Co Ltd Influenzavirus B Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 208. Shionogi & Co Ltd Main Business

Table 209. Shionogi & Co Ltd Latest Developments

Table 210. SK Chemicals Co Ltd Basic Information, Influenzavirus B Infection Drug Manufacturing Base, Sales Area and Its Competitors

Table 211. SK Chemicals Co Ltd Influenzavirus B Infection Drug Product Offered

Table 212. SK Chemicals Co Ltd Influenzavirus B Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 213. SK Chemicals Co Ltd Main Business

Table 214. SK Chemicals Co Ltd Latest Developments

Table 215. TSRL Inc Basic Information, Influenzavirus B Infection Drug Manufacturing Base, Sales Area and Its Competitors

Table 216. TSRL Inc Influenzavirus B Infection Drug Product Offered

Table 217. TSRL Inc Influenzavirus B Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 218. TSRL Inc Main Business

Table 219. TSRL Inc Latest Developments

Table 220. Vaxart Inc Basic Information, Influenzavirus B Infection Drug Manufacturing Base, Sales Area and Its Competitors

Table 221. Vaxart Inc Influenzavirus B Infection Drug Product Offered

Table 222. Vaxart Inc Influenzavirus B Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 223. Vaxart Inc Main Business

Table 224. Vaxart Inc Latest Developments

Table 225. Vectura Group Plc Basic Information, Influenzavirus B Infection Drug Manufacturing Base, Sales Area and Its Competitors

Table 226. Vectura Group Plc Influenzavirus B Infection Drug Product Offered

Table 227. Vectura Group Plc Influenzavirus B Infection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 228. Vectura Group Plc Main Business

Table 229. Vectura Group Plc Latest Developments

List of Figures

Figure 1. Picture of Influenzavirus B Infection Drug

Figure 2. Influenzavirus B Infection Drug Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Influenzavirus B Infection Drug Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Influenzavirus B Infection Drug Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Influenzavirus B Infection Drug Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of APP-309

Figure 10. Product Picture of CF-403

Figure 11. Product Picture of GC-3106A

Figure 12. Product Picture of KIN-1400

Figure 13. Product Picture of Others

Figure 14. Global Influenzavirus B Infection Drug Sales Market Share by Type in 2021

Figure 15. Global Influenzavirus B Infection Drug Revenue Market Share by Type (2017-2022)

Figure 16. Influenzavirus B Infection Drug Consumed in Clinic

Figure 17. Global Influenzavirus B Infection Drug Market: Clinic (2017-2022) & (K Pcs)

Figure 18. Influenzavirus B Infection Drug Consumed in Hospital

Figure 19. Global Influenzavirus B Infection Drug Market: Hospital (2017-2022) & (K Pcs)

Figure 20. Influenzavirus B Infection Drug Consumed in Others

Figure 21. Global Influenzavirus B Infection Drug Market: Others (2017-2022) & (K Pcs)

Figure 22. Global Influenzavirus B Infection Drug Sales Market Share by Application (2017-2022)

Figure 23. Global Influenzavirus B Infection Drug Revenue Market Share by Application in 2021

Figure 24. Influenzavirus B Infection Drug Revenue Market by Company in 2021 ($ Million)

Figure 25. Global Influenzavirus B Infection Drug Revenue Market Share by Company in 2021

Figure 26. Global Influenzavirus B Infection Drug Sales Market Share by Geographic Region (2017-2022)

Figure 27. Global Influenzavirus B Infection Drug Revenue Market Share by Geographic Region in 2021

Figure 28. Global Influenzavirus B Infection Drug Sales Market Share by Region (2017-2022)

Figure 29. Global Influenzavirus B Infection Drug Revenue Market Share by Country/Region in 2021

Figure 30. Americas Influenzavirus B Infection Drug Sales 2017-2022 (K Pcs)

Figure 31. Americas Influenzavirus B Infection Drug Revenue 2017-2022 ($ Millions)

Figure 32. APAC Influenzavirus B Infection Drug Sales 2017-2022 (K Pcs)

Figure 33. APAC Influenzavirus B Infection Drug Revenue 2017-2022 ($ Millions)

Figure 34. Europe Influenzavirus B Infection Drug Sales 2017-2022 (K Pcs)

Figure 35. Europe Influenzavirus B Infection Drug Revenue 2017-2022 ($ Millions)

Figure 36. Middle East & Africa Influenzavirus B Infection Drug Sales 2017-2022 (K Pcs)

Figure 37. Middle East & Africa Influenzavirus B Infection Drug Revenue 2017-2022 ($ Millions)

Figure 38. Americas Influenzavirus B Infection Drug Sales Market Share by Country in 2021

Figure 39. Americas Influenzavirus B Infection Drug Revenue Market Share by Country in 2021

Figure 40. United States Influenzavirus B Infection Drug Revenue Growth 2017-2022 ($ Millions)

Figure 41. Canada Influenzavirus B Infection Drug Revenue Growth 2017-2022 ($ Millions)

Figure 42. Mexico Influenzavirus B Infection Drug Revenue Growth 2017-2022 ($ Millions)

Figure 43. Brazil Influenzavirus B Infection Drug Revenue Growth 2017-2022 ($ Millions)

Figure 44. APAC Influenzavirus B Infection Drug Sales Market Share by Region in 2021

Figure 45. APAC Influenzavirus B Infection Drug Revenue Market Share by Regions in 2021

Figure 46. China Influenzavirus B Infection Drug Revenue Growth 2017-2022 ($ Millions)

Figure 47. Japan Influenzavirus B Infection Drug Revenue Growth 2017-2022 ($ Millions)

Figure 48. South Korea Influenzavirus B Infection Drug Revenue Growth 2017-2022 ($ Millions)

Figure 49. Southeast Asia Influenzavirus B Infection Drug Revenue Growth 2017-2022 ($ Millions)

Figure 50. India Influenzavirus B Infection Drug Revenue Growth 2017-2022 ($ Millions)

Figure 51. Australia Influenzavirus B Infection Drug Revenue Growth 2017-2022 ($ Millions)

Figure 52. Europe Influenzavirus B Infection Drug Sales Market Share by Country in 2021

Figure 53. Europe Influenzavirus B Infection Drug Revenue Market Share by Country in 2021

Figure 54. Germany Influenzavirus B Infection Drug Revenue Growth 2017-2022 ($ Millions)

Figure 55. France Influenzavirus B Infection Drug Revenue Growth 2017-2022 ($ Millions)

Figure 56. UK Influenzavirus B Infection Drug Revenue Growth 2017-2022 ($ Millions)

Figure 57. Italy Influenzavirus B Infection Drug Revenue Growth 2017-2022 ($ Millions)

Figure 58. Russia Influenzavirus B Infection Drug Revenue Growth 2017-2022 ($ Millions)

Figure 59. Middle East & Africa Influenzavirus B Infection Drug Sales Market Share by Country in 2021

Figure 60. Middle East & Africa Influenzavirus B Infection Drug Revenue Market Share by Country in 2021

Figure 61. Egypt Influenzavirus B Infection Drug Revenue Growth 2017-2022 ($ Millions)

Figure 62. South Africa Influenzavirus B Infection Drug Revenue Growth 2017-2022 ($ Millions)

Figure 63. Israel Influenzavirus B Infection Drug Revenue Growth 2017-2022 ($ Millions)

Figure 64. Turkey Influenzavirus B Infection Drug Revenue Growth 2017-2022 ($ Millions)

Figure 65. GCC Country Influenzavirus B Infection Drug Revenue Growth 2017-2022 ($ Millions)

Figure 66. Manufacturing Cost Structure Analysis of Influenzavirus B Infection Drug in 2021

Figure 67. Manufacturing Process Analysis of Influenzavirus B Infection Drug

Figure 68. Industry Chain Structure of Influenzavirus B Infection Drug

Figure 69. Channels of Distribution

Figure 70. Distributors Profiles